QUANTITATIVE-ANALYSIS OF PRE-S1 AND PRE-S2 IN RELATION TO HBSAG EXPRESSION

被引:9
|
作者
YUKI, N [1 ]
HAYASHI, N [1 ]
KATAYAMA, K [1 ]
KASAHARA, A [1 ]
UEDA, K [1 ]
FUSAMOTO, H [1 ]
SATO, N [1 ]
KAMADA, T [1 ]
机构
[1] OSAKA UNIV,SCH MED,DEPT MED 1,FUKUSHIMA 1-1-50,FUKUSHIMA KU,OSAKA 553,JAPAN
关键词
D O I
10.1002/hep.1840110108
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Sera from four patients with acute hepatitis B and 87 patients with chronic hepatitis B were examined quantitatively for pre‐S1 and pre‐S2 antigens by solid‐phase enzyme immunoassays. Pre‐S1 and pre‐S2 antigens were detected in HBsAg‐positive sera irrespective of the presence of viral replicative markers, and their titers correlated with those of HbsAg(r = 0.74, p < 0.01; r = 0.74, p < 0.01, respectively). Sera positive for HBeAg showed higher titers of pre‐S1 (p < 0.01) and pre‐S2 (p < 0.01) antigens than sera negative for HBeAg. The titers of pre‐S1 and pre‐S2 antigens also correlated with the levels of HBV‐associated DNA polymerase activity (r = 0.51, p < 0.01; r = 0.59, p < 0.01, respectively) and HBV‐DNA (r = 0.50, p < 0.01; r = 0.46, p < 0.01, respectively). However, the ratios between the titers of pre‐S antigens and HBsAg had no significant relationships with those viral replicative markers. These findings suggest that the expression of pre‐S antigens is intimately related to the expression of HBsAg and that they are not useful as markers of viral replication. The ratios between the titers of pre‐S antigens and HBsAg tended to be high in patients with chronic active hepatitis and high aminotransferase levels. This finding may have been due to the hepatic release of pre‐S antigens, overproduction of which may have some relationship to liver injury. Copyright © 1990 American Association for the Study of Liver Diseases
引用
收藏
页码:38 / 43
页数:6
相关论文
共 50 条
  • [41] HLA haplotypes associated with antibody non-responders to the present hepatitis B vaccine and with their response to a pre-S1 and pre-S2 containing hepatitis B vaccine
    McDermott, AB
    Zuckerman, JN
    Sabin, CA
    Madrigal, A
    HLA - GENETIC DIVERSITY OF HLA FUNCTIONAL AND MEDICAL IMPLICATION, PROCEEDINGS OF THE TWELFTH INTERNATIONAL HISTOCOMPATIBILITY WORKSHOP AND CONFERENCE (12TH IHWC), VOL II: CONFERENCE, 1997, : 695 - 697
  • [42] Pre-S1、HBsAg和肝功能相关性探讨
    王容
    中国妇幼健康研究, 2016, (S2) : 205 - 205
  • [43] Pre-S1 Ag、Pre-S2 Ag及HBV-LP在乙肝病毒检测中的性能比较
    刘爱云
    于欣
    马苏琳
    菏泽医学专科学校学报, 2020, 32 (02) : 23 - 25+31
  • [44] 2 VACCINIA VIRUS RECOMBINANTS EXPRESSING HBSAG WITH DIFFERENT CONCENTRATION OF A-S2 AND PRE-S2 ANTIGENIC DETERMINANTS
    CHELYAPOV, NV
    RAKHILINA, LE
    ANTONOVA, TP
    CHERNOS, VI
    GRIGORJEV, VG
    CHUDAKOVA, EA
    PASHVYKINA, GV
    ZAKHAROVA, LG
    ALTSTEIN, AD
    KUTINOVA, L
    HAMSIKOVA, E
    NEMECKOVA, S
    ACTA VIROLOGICA, 1991, 35 (05) : 413 - 422
  • [45] PRE-S1 PROTEINS IN SERA OF PATIENTS POSITIVE FOR HBSAG AND ANTIBODIES TO HEPATITIS-DELTA VIRUS
    THEILMANN, L
    GMELIN, K
    TAPALAGA, D
    SALFELD, J
    KOMMERELL, B
    PFAFF, E
    HEPATO-GASTROENTEROLOGY, 1987, 34 (02) : 53 - 55
  • [46] ANTIBODIES TO SYNTHETIC PEPTIDES FROM THE PRE-S1 AND PRE-S2 REGIONS OF ONE SUBTYPE OF THE HEPATITIS-B VIRUS (HBV) ENVELOPE PROTEIN RECOGNIZE ALL HBV SUBTYPES
    NEURATH, AR
    KENT, SBH
    STRICK, N
    PARKER, K
    COUROUCE, AM
    RIOTTOT, MM
    PETIT, MA
    BUDKOWSKA, A
    GIRARD, M
    PILLOT, J
    MOLECULAR IMMUNOLOGY, 1987, 24 (09) : 975 - 980
  • [47] PRE-S2 ANTIBODIES IN HEPATITIS-B
    AIHARA, S
    ISE, I
    TSUDA, F
    TAKAI, E
    MACHIDA, A
    MIYAKAWA, Y
    LANCET, 1986, 2 (8521-2): : 1457 - 1458
  • [48] A SOLID-PHASE ENZYME-IMMUNOASSAY FOR THE DETERMINATION OF IGM AND IGG ANTIBODIES AGAINST TRANSLATION PRODUCTS OF PRE-S1 AND PRE-S2 REGIONS OF HEPATITIS-B VIRUS
    TAKAI, E
    MACHIDA, A
    OHNUMA, H
    MIYAMOTO, H
    TANAKA, T
    BABA, K
    TSUDA, F
    USUDA, S
    NAKAMURA, T
    MIYAKAWA, Y
    MAYUMI, M
    JOURNAL OF IMMUNOLOGICAL METHODS, 1986, 95 (01) : 23 - 30
  • [49] SERIAL STUDIES OF PRE-S2 AND ANTI-PRE-S2 IN FULMINANT HEPATITIS-B
    BRAHM, J
    FAGAN, EA
    BUDKOWSKA, A
    ROLANDO, N
    OGRADY, J
    PILLOT, J
    WILLIAMS, R
    EDDLESTON, A
    JOURNAL OF HEPATOLOGY, 1987, 5 : S99 - S99
  • [50] Safety and immunogenicity of a novel mammalian cell-derived recombinant hepatitis B vaccine containing Pre-S1 and Pre-S2 antigens in neonates (vol 16, pg 587, 1997)
    Yerushalmi, B
    Raz, R
    Blondheim, O
    Shumov, E
    Koren, R
    Dagan, R
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1997, 16 (11) : 1037 - 1037